Variables | Univariable analysis N = 3429 Phlebitis: 313 (9.1%) | Multivariable analysis N = 2460 Phlebitis: 247 (10.0%) | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
ICU characteristics | ||||
 Drug administration standardization | 0.36 (0.20–0.66) | 0.0009 | 0.35 (0.17–0.76) | 0.007 |
 Education on venous catheter management for nurses | 1.29 (1.03–1.63) | 0.03 | 1.15 (0.86–1.54) | 0.35 |
Patient characteristics | ||||
 Age | 1.01 (0.99–1.01) | 0.15 | 1.01 (0.99–1.02) | 0.28 |
 Gender, male | 0.69 (0.55–0.86) | 0.0009 | 0.85 (0.64–1.12) | 0.24 |
 BMI |  |  |  |  |
  16–22 | Ref. | - | Ref. | - |
  ≤15 | 1.14 (0.45–2.90) | 0.78 | 1.18 (0.60–2.33) | 0.62 |
  23–29 | 0.95 (0.62–1.46) | 0.83 | 0.86 (0.65–1.14) | 0.29 |
  30≤ | 0.58 (0.14–2.38) | 0.45 | 0.43 (0.20–0.95) | 0.04 |
 APACHE II |  |  |  |  |
  16–25 | Ref. | – | Ref. | – |
  ≤15 | 1.09 (0.85–1.39) | 0.49 | 1.07 (0.79–1.45) | 0.65 |
  25 <  | 0.77 (0.56–1.05) | 0.10 | 0.70 (0.48–1.01) | 0.06 |
Catheter characteristics | Â | Â | Â | Â |
 Catheter inserted by (n,%) |  |  |  |  |
  Nurse | Ref. | – | Ref. | – |
  Doctor | 0.55 (0.35–0.86) | 0.009 | 0.55 (0.32–0.94) | 0.03 |
 Number of trials for insertion (n,%) |  |  |  |  |
  1 | Ref. | – | Ref. | – |
  2 | 0.90 (0.60–1.34) | 0.59 | 1.01 (0.67–1.53) | 0.95 |
  3 | 1.44 (0.89–2.32) | 0.14 | 1.35 (0.81–2.24) | 0.25 |
  ≥4 | 0.84 (0.35–2.04) | 0.70 | 1.34 (0.54–3.33) | 0.53 |
 Use of ultrasonography | 0.51 (0.19–1.38) | 0.19 | 0.78 (0.24–2.56) | 0.68 |
 Inserted site |  |  |  |  |
  Forearm | Ref. |  | Ref. |  |
  Upper arm | 0.61 (0.39–0.95) | 0.03 | 0.52 (0.32–0.85) | 0.009 |
  Elbow | 0.84 (0.50–1.43) | 0.53 | 0.95 (0.50–1.79) | 0.87 |
  Wrist | 0.70 (0.38–1.28) | 0.24 | 0.56 (0.26–1.21) | 0.14 |
  Hand | 0.58 (0.40–0.84) | 0.004 | 0.67 (0.43–1.04) | 0.08 |
  Lower leg | 0.87 (0.56–1.34) | 0.52 | 0.74 (0.46–1.21) | 0.23 |
  Dorsal foot | 0.96 (0.58–1.57) | 0.86 | 0.95 (0.55–1.66) | 0.87 |
 Catheter size |  |  |  |  |
  22–24G | Ref. |  | Ref. |  |
  ≥18G | 0.99 (0.60–1.61) | 0.96 | 1.97 (0.68–5.77) | 0.21 |
  20G | 0.59 (0.44–0.79) | 0.0004 | 0.75 (0.52–1.08) | 0.12 |
 Dressing |  |  |  |  |
  Sterile dressing | Ref. |  | Ref. |  |
  Non-sterile dressing | 1.36 (0.70–2.64) | 0.36 | 0.90 (0.28–2.89) | 0.86 |
 Catheter material |  |  |  |  |
  Polyurethane | Ref. |  | Ref. |  |
  PEU-Vialon* | 0.61 (0.46–0.81) | 0.0007 | 0.70 (0.49–1.02) | 0.06 |
  Tetrafluoroethylene | 0.84 (0.64–1.09) | 0.18 | 0.99 (0.71–1.38) | 0.95 |
  Others | 1.37 (0.72–2.62) | 0.34 | 0.94 (0.21–4.16) | 0.93 |
  Infection during catheter dwell | 1.10 (0.86–1.40) | 0.47 | 1.36 (0.99–1.85) | 0.06 |
Drug characteristics | ||||
 Fentanyl (n, %) | 0.89 (0.65–1.21) | 0.45 | 0.81 (0.54–1.21) | 0.29 |
 Heparin | 0.62 (0.42–0.92) | 0.02 | 0.65 (0.40–1.07) | 0.09 |
 Fat | 1.89 (1.04–3.41) | 0.04 | 0.67 (0.40–1.10) | 0.11 |
 Nicardipine | 1.97 (1.46–2.65) |  < 0.0001 | 1.85 (1.29–2.66) | 0.0008 |
 Dexmedetomidine | 1.16 (0.83–1.61) | 0.38 | 1.08 (0.72–1.63) | 0.70 |
 Ampicillin/sulbactam | 1.00 (0.63–1.57) | 0.99 | 0.79 (0.47–1.31) | 0.36 |
 Albumin | 0.87 (0.44–1.71) | 0.68 | 1.36 (0.82–2.23) | 0.23 |
 Paracetamol | 0.63 (0.34–1.18) | 0.15 | 0.69 (0.33–1.46) | 0.33 |
 Potassium | 1.62 (1.08–2.42) | 0.02 | 1.32 (0.79–2.21) | 0.30 |
 Meropenem | 0.76 (0.46–1.26) | 0.28 | 0.99 (0.52–1.87) | 0.96 |
 Steroid | 0.62 (0.32–1.20) | 0.16 | 0.68 (0.32–1.43) | 0.31 |
 Ceftriaxone | 0.88 (0.51–1.54) | 0.66 | 0.69 (0.37–1.31) | 0.26 |
 Vancomycin | 0.42 (0.20–0.87) | 0.02 | 0.43 (0.18–1.03) | 0.06 |
 Magnesium | 0.98 (0.54–1.79) | 0.95 | 0.68 (0.27–1.69) | 0.40 |
 PPN | 0.90 (0.48–1.69) | 0.74 | 0.78 (0.37–1.62) | 0.50 |
 Phosphorus | 1.30 (0.73–2.31) | 0.38 | 1.11 (0.53–2.33) | 0.79 |
 Noradrenaline | 2.54 (1.60–4.04) |  < 0.0001 | 2.42 (1.40–4.20) | 0.002 |
 Carperitide | 1.13 (0.64–2.02) | 0.67 | 0.93 (0.46–1.84) | 0.83 |
 Midazolam | 1.63 (0.92–2.91) | 0.10 | 1.50 (0.72–3.11) | 0.28 |
 Nitroglycerin | 0.73 (0.32–1.63) | 0.44 | 0.22 (0.05–0.92) | 0.04 |
 Dobutamine | 1.54 (0.73–3.26) | 0.26 | 1.14 (0.48–2.68) | 0.77 |
 Cefmetazole | 1.20 (0.45–3.22) | 0.72 | 0.92 (0.22–3.82) | 0.90 |
 Amiodarone | 2.34 (1.21–4.55) | 0.01 | 3.67 (1.75–7.71) | 0.0006 |
 Cefepime | 0.58 (0.22–1.56) | 0.28 | 0.70 (0.25–1.96) | 0.49 |
 Levetiracetam | 1.54 (0.21–11.1) | 0.67 | 5.65 (2.80–11.4) |  < 0.0001 |
 Landiolol | 0.75 (0.28–2.00) | 0.56 | 0.73 (0.23–2.38) | 0.61 |